Extrapyramidal syndrome
EPS
affected
antipsychotic drugs
affinity
D2 receptor
research groups
positive
relationship
genetic variations
DRD2 gene
therapeutic response
schizophrenia
patients
variations
receptor
modulating
receptor
expression
study
evaluate
DRD2
chlorpromazine-induced
EPS
schizophrenic
patients
